OLMESARTAN AMLO HCT Mepha Lactab 20/5/12.5 28 pce
7680676020019
CH-67602
C09DX03
02.07.2.
Reimbursement limitations:
OLMAMLHCTMEP
Le traitement combiné d’une association fixe d’olmésartan-amlodipine ou d’olmésartan-amlodipine-hydrochlorothiazide et d'un antagoniste du calcium I.T. …
1 / 3
google
Details
- Product number
- 6760201
- CPT
- -
- Packaging group
- 28
- Unit
- Tablette(n)
- Composition
- Filmtablette: olmesartanum medoxomilum 20 mg, amlodipinum 5 mg ut amlodipini besilas 6.93 mg, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, lactosum monohydricum 19 mg, crospovidonum povidonum K 30, carboxymethylamylum natricum A corresp. natrium 0.21 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 4000, talcum, pro compresso obducto.
Articles (1)
Olmesartan-Amlodipin-HCT-Mepha 20 mg/5 mg/12,5 mg, Filmtabletten
Filmtabletten
28
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
FTAB
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
FTAB
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
FTAB
|
6.93 MG | Substance | WIZUS |
|
FTAB
|
12.5 MG | Substance | Wirkstoff (Principe actif) |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
19.0 MG | Substance | HBESI |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
0.21 MG | Substance | HBESI |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | FNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 33.75
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/12/2020
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 67602
- Drug name
- Olmesartan-Amlodipin-HCT-Mepha, Filmtabletten
- Galenic form
- FILM
- ATC Code
- C09DX03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 11/08/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 02.07.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OLMESARTAN AMLO HCT Mepha Lactab 20/5/12.5 28 pce
- Description (DE)
- OLMESARTAN AMLO HCT Mepha Lactab 20/5/12.5 28 Stk
- Market launch
- 11/08/2020
- Narcotic (BTM)
- No